- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04589702
Temporal Activation of Core Muscles and Vasti in Isolated Patellofemoral Osteoarthritis
Temporal Activation of Core Muscles and Vasti in Isolated Patellofemoral Osteoarthritis During Stair-stepping
Study Overview
Status
Conditions
Detailed Description
Investigators collected the EMG activity of VMO, VL, GM, multifidus, and TrA using bipolar Ag-AgCl disposable surface electrodes (Better signal solution medical supply Co., limited, Zhongshan, China) and eight channels high-resolution wireless bio amplifier (WBA) system (Biomation, Almonte, Canada). Electromyographic data were sampled at 1000 Hz and bandpass filtered at 50-200 Hz.
For each muscle, three electrodes were used; two electrodes were placed ~ 30 mm apart in the direction of the muscle fibers and a ground electrode was placed over the closest bony prominence. Before placement of the electrodes, the subject's skin was cleaned with alcohol to reduce impedance and excess hair was removed to eliminate shifting of the electrodes if needed.
The stair-stepping task consisted of ascending 2 steps (each step was 40 cm in width, 20 cm in height, without handrails. The depth of the first and second steps was 30 cm and 40 cm, respectively) . Participants were asked to stand on the floor confronting the stairs and 20 cm away from the edge of the initial step. The stair ascent task was performed barefooted while arms hanged at the side of the body. Patients started ascending the steps immediately in response to a command, at their normal speed with their affected limb. Investigators didn't control the speed of stair ascent, because controlling the timing of stair-stepping can alter the electromyographic signal as shown earlier for gait in asymptomatic subjects. Healthy subjects started ascending stairs with their dominant limb .
Before data acquisition, participants performed one practice trial of stair ascent to get familiarized with the task. Then the participants performed three test trials with thirty seconds of rest after each trial to prevent fatigue. The raw data were stored on a personal computer for analysis with a custom program in Matlab (Math Works, Natick, Massachusetts, USA). Investigators used a mean of data in three trials for analysis.
Statistical Analysis:
Data management and analysis were conducted using the statistical package for social studies (SPSS) version 22 for windows (IBM SPSS, Chicago, IL, USA). Normal distribution of the data was tested using the Shapiro-Wilk test. The homogeneity of variances between groups was examined using Levene's test. Descriptive data are expressed as mean ± standard deviation. An independent t-test was conducted for comparison of subject characteristics; age, body mass index (BMI), weight and height, between both groups. A univariate test of one way MANOVA was performed to compare EMG onset of each muscle between both groups. Post-hoc analysis using the Bonferroni method was carried out for subsequent multiple comparison. The level of significance for all statistical tests was set at p < 0.05.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Giza, Egypt, 11432
- Faculty of Physical Therapy, Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria for PF OA group; patients included if they had
- Anterior- or retro-patellar knee pain aggravated by at least two activities that load the PFJ (eg; stair ambulation, squatting and/or rising from sitting) .
- Pain during these activities presented on most days during the past month and their pain severity was ≥ 4 on an 11 point numerical pain scale during aggravating activities .,
- A grade less than (2) from postero-anterior views on the Kellgren - Lawrence (KL) grading scale.
Inclusion Criteria for Healthy control subjects :
1. no history of knee pathology or pain with any of the provocative activities which were mentioned above.
Exclusion Criteria for Patients in the PF OA group:
1. concomitant pain from tibiofemoral joint or other knee structures .
Exclusion Criteria for Subjects from both groups:
- current or previous pain in the hip, lumbar spine or foot that had lasted longer than 3 months and/or required intervention.
- a history of lower extremity, pelvis or spine fractures; spine, hip, knee or foot surgeries; hip or patellar subluxation/ dislocation.
- injury to any of knee ligaments or meniscus.
systemic diseases (e.g. rheumatoid arthritis), neurological conditions or fibromyalgia . 5.The professional athletes; people who exercise more than two hours a day or every other day, were also excluded .
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
females with isolated patellofemoral arthritis
those with anterior knee pain
|
|
healthy females
those without anterior knee pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The EMG onset of multifidus, transversus abdominus (TrA), gluteus medius (GM), and vasti muscles
Time Frame: from admission to discharge, up to two weeks
|
investigators collected the EMG activity of VMO, VL, GM, multifidus, and TrA using bipolar Ag-AgCl disposable surface electrodes (Better signal solution medical supply Co., limited, Zhongshan, China) and eight channels high-resolution wireless bio amplifier (WBA) system (Biomation, Almonte, Canada).
|
from admission to discharge, up to two weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Aladdin A. balbaa, professor, Cairo University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- (P.T.Rec/012/001659)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chondromalacia Patellae
-
University of Sao Paulo General HospitalCompleted
-
Cairo UniversityCompletedChondromalacia PatellaeEgypt
-
Cairo UniversityRecruitingChondromalacia PatellaEgypt
-
Instituto Mexicano del Seguro SocialCompletedChondromalacia PatellaeMexico
-
Kayseri City HospitalCompletedChondromalacia PatellaeTurkey
-
University of VirginiaCompletedPatellofemoral Pain Syndrome | Chondromalacia PatellaUnited States
-
Cairo UniversityCompletedIs Lower Limb Neuromotor Control Diverse in Females With PF OA Contrasted With Asymptomatic ControlsChondromalacia PatellaeEgypt
-
Sheba Medical CenterZinman College of Physical Education and Sports SciencesUnknownCartilage Diseases | ChondromalaciaIsrael
-
Istanbul Medipol University HospitalRecruiting
-
Gaziler Physical Medicine and Rehabilitation Education...RecruitingChondromalacia PatellaeTurkey